NCT03169361View on ClinicalTrials.gov

"NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) Relapsed/Refractory Multiple Myeloma"

CompletedOBSERVATIONAL
Enrollment

774

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

March 8, 2022

Study Completion Date

March 8, 2022

Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03169361 - "NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) Relapsed/Refractory Multiple Myeloma" | Biotech Hunter | Biotech Hunter